# Advisor Review - Gemini-3-Flash

**Role:** Academic advisor checking for fatal errors
**Model:** gemini-3-flash-preview (ai_studio)
**Paper:** paper.pdf
**Timestamp:** 2026-02-27T16:29:36.523335
**Route:** Direct Google API + PDF
**Paper Hash:** 35b9d8bed741b5ee
**Tokens:** 17798 in / 592 out
**Response SHA256:** ba6efeeaf4090291

---

I have reviewed the paper "Downtown for Sale? Commercial Displacement Effects of France’s Action Cœur de Ville Program" for fatal errors.

**1. DATA-DESIGN ALIGNMENT**
- **Treatment vs. Coverage:** The paper evaluates the ACV program (launched in 2018) using a panel from 2010Q1 to 2024Q4. The treatment date is set at 2018Q1. The data coverage (ending 2024) is sufficient to observe effects for the treatment period described.
- **Post-treatment observations:** There are approximately 28 quarters of post-treatment data (2018–2024), providing ample observations for each cohort.
- **RDD/DiD Cutoffs:** The event study (Figure 2) shows data on both sides of the 2018Q1 cutoff.

**2. REGRESSION SANITY**
- **Standard Errors:** In Table 3, SEs are in the range of 0.009 to 0.15 for outcomes with means around 0.23–1.87. This is within a normal range.
- **Coefficients:** The coefficients for log outcomes (Table 3, Column 2) are -0.0081, which is plausible. The largest coefficient is -0.2572 for "All Sectors," which is reasonable given the outcome mean.
- **Impossible Values:** $R^2$ values in Table 3 range from 0.04 to 0.28, which are valid. No negative SEs or "NaN" values were found in the results.

**3. COMPLETENESS**
- **Placeholders:** I scanned the text and tables for "TBD", "PLACEHOLDER", or empty cells. Table 1, 2, 3, 4, and 5 are fully populated. 
- **Required Elements:** Sample sizes (N=18,120) are clearly reported in all regression tables. Standard errors are provided in parentheses.
- **Internal References:** Figures 1-6 and Tables 1-5 are all present and match the descriptions in the text.

**4. INTERNAL CONSISTENCY**
- **Number Matching:** The coefficient reported in the Abstract ($\beta = -0.040, SE = 0.039$) matches the "Baseline" result in Table 3 and Table 5.
- **Timing Consistency:** The treatment onset (2018Q1) is applied consistently across all analyses and figures.
- **Sample Consistency:** The observation count (18,120) is consistent across all main regression specifications.

**ADVISOR VERDICT: PASS**